BROKER FORECASTS
81

Most upside (3 months)

The Most Upside chart above shows the companies potential share price gain (%) (the potential share price increase from the current share to the broker target price)

  Company % change  
  Petrofac Ltd 221.34  
  Hikma Pharmaceuticals PLC 100.95  
  Tullow Oil PLC 78.66  
  Lonmin PLC 68.12  
  Imagination Technologies Group PLC 67.03  
  BT Group PLC 51.32  
  Petra Diamonds Ltd 50.72  
  Amerisur Resources PLC 46.94  
  Rio Tinto PLC 40.79  
  Acacia Mining Plc 36.53  
  Glencore PLC 33.33  
  Paddy Power Betfair 32.29  
  Royal Dutch Shell 32.09  
  BP PLC 31.70  
  Ladbrokes Coral Group Plc 29.71  

Performance Analysis (6 Months)

The performance analysis chart above provides a detailed breakdown of Buy, Sell and Hold recommendations for the selected bank or stockbroker. To see a full explanation of how to use this chart, please visit the performance analysis explanation page.

Recommendation Summary (3 months)

Barclays Capital News

  • Broker views: Pharma and mining

    19 May 2017 | Shire
    Equity analysts at HSBC have downgraded their investment rating on Shire Pharmaceuticals (LON:SHP) to 'reduce' (from 'hold'), despite the company reporting positive data from the HELP study...
  • Broker views: Banks and satellites

    05 May 2017 | Barclays
    Equity research analysts at Goldman Sachs have downgraded their investment rating on banking group Barclays (LON:BARC) to sell (from neutral), believing the continued capital build is likely to...
  • Drax double-upgraded by Jefferies

    02 May 2017 | Drax Group
    Jefferies International has double-upgraded its investment rating on Drax (LON:DRX) and moved straight to buy (from underperform) on the expectation of an 18.5p dividend. The broker said: "We...
  • Drax upgraded by Barclays

    28 April 2017 | Drax Group
    Equity research analysts at Barclays Capital have upgraded their investment rating on Drax (LON:DRX) to overweight (from equal weight), believing the post-results stock weakness is unjustified....
  • Broker views: Insurance, textiles and oil

    21 March 2017 | esure Group
    Citigroup has downgraded its recommendation on insurance group esure (LON:ESUR) to neutral (from buy), which it says is given the strong performance year-to-date and the limited scope for...

Barclays Capital Notes